# China NMPA Drug Inspection - Shanghai Dedatang Traditional Chinese Medicine Co., Ltd. - Corydalis

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shanghai-dedatang-traditional-chinese-medicine-co-ltd/c92443a2-40c9-48d5-bfc3-1a61bc9c47ae/
Source feed: China

> China NMPA drug inspection for Shanghai Dedatang Traditional Chinese Medicine Co., Ltd. published January 12, 2017. Drug: Corydalis. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement No. 5 of 2017 from the State Administration for Market Regulation on the Results of Special Sampling Inspections of Chinese Medicinal Herbs and Prepared Slices
- Company Name: Shanghai Dedatang Traditional Chinese Medicine Co., Ltd.
- Publication Date: 2017-01-12
- Drug Name: Corydalis
- Inspection Finding: Auramine O was detected, indicating a staining problem. Additionally, some batches of products did not meet the requirements for appearance, identification, or content determination.
- Action Taken: We have taken timely and lawful measures to control the products, including sealing and seizing, suspending production and sales, and requiring companies to voluntarily recall their products. We have also filed cases against the relevant companies and units for investigation and punishment.

Company: https://www.globalkeysolutions.net/companies/shanghai-dedatang-traditional-chinese-medicine-co-ltd/6d4fd4ca-b898-4c08-ab3c-076ce5371db4/